Harton Therapeutics
Founded 2021 · 11 employees on LinkedIn · 1 known investors
Harton Therapeutics offers a GMP-ready platform for advanced 3D cell manufacturing, using a perfusion-based single-use cartridge system with automated process control to produce human cells at scale. It serves researchers, biotech and pharma teams, and manufacturing partners working on immune cell therapies, HSPCs, engineered cells, and stem-derived cells and tissues.
Investors · 1
In the news
Frequently asked questions
- What does Harton Therapeutics do?
- Harton Therapeutics offers a GMP-ready platform for advanced 3D cell manufacturing, using a perfusion-based single-use cartridge system with automated process control to produce human cells at scale. It serves researchers, biotech and pharma teams, and manufacturing partners working on immune cell therapies, HSPCs, engineered cells, and stem-derived cells and tissues.
- Who are Harton Therapeutics's investors?
- Harton Therapeutics's investors include Decheng Capital.